FC

Fakir Chand

Active Director Director DIN 08370989
DIN 08370989 First appointment Feb 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2019
Shareholding value •••• Premium profile

About Fakir Chand

Data last updated:

Fakir Chand is a Director at Almatica Pharmaceuticals Private Limited (since 2019). The company operates in Pharma. Almatica Pharmaceuticals Private Limited reported revenue of ₹2.89 Cr (FY 2024).

DIN 08370989
Primary Designation Director
Industry Pharma
First Appointment 15 Feb 2019
Oldest Company Age 7 yrs
Largest company Almatica Pharmaceuticals Private Limited · ₹2.89 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Feb 20192019₹2.89 Cr (FY 2024)Active

Board colleagues of Fakir Chand

Directorship timeline

Open interactive timeline →
Almatica Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Fakir Chand

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Fakir Chand

Fakir Chand currently holds 1 directorship: Almatica Pharmaceuticals Private Limited (Director, since 15 Feb 2019, revenue ₹2.89 Cr (FY 2024)).

Fakir Chand was first appointed on 15 Feb 2019 as Director at Almatica Pharmaceuticals Private Limited.

The current boards of Fakir Chand's companies include Shiv Kumar Gupta (Almatica Pharmaceuticals Private Limited), Vibhor Gupta (Almatica Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available